Clinical outcomes of carbapenem therapy in OXA-48–producing Enterobacterales infections: a French multicentre cohort, systematic review, and meta-analysis

OXA-48–producing Enterobacterales (OXA-48-PE) represent a growing global health threat. Most of OXA-48–PE remain categorized susceptible to carbapenems, which might encourage their use despite uncertain clinical efficacy. This study evaluated clinical outcomes of infections caused by OXA-48-PE treat...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Laurent Dortet, Charlotte Moreau, Aurélien Dinh, Rémy A. Bonnin, Lélia Escaut, Manon Seguret, Laura Weber, Samy Figueiredo, Benoît Pilmis
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Taylor & Francis Group 2026-12-01
Rangatū:	Emerging Microbes and Infections
Ngā marau:	OXA-48 carbapenemase-producing Enterobacterales carbapenem therapy ceftazidime-avibactam antimicrobial resistance meta-analysis
Urunga tuihono:	https://www.tandfonline.com/doi/10.1080/22221751.2026.2671518
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!